8 September 2025CompletedHealthcare
Novartis AG to acquire Tourmaline Bio, Inc.
Novartis AG and Tourmaline Bio, Inc. entered the Exit Mode archive.
- Buyer
- Novartis AG
- Target
- Tourmaline Bio, Inc.
- Deal value
- USD 1,153,403,296
- Deal type
- going private
Buyer profile
Novartis AG
Every published deal in the Exit Mode archive where this buyer appears on the acquiring side.
Country
Switzerland
Deal count
1
Buyer type
Corporate / other
Aggregate disclosed value
Not stated
Keep browsing